Consensus Artivion, Inc.

Stocks

AORT

US2289031005

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 01:30:03 27/06/2026 am IST			5-day change	1st Jan Change
23.61 ^USD	+4.19%		+11.42%	-48.24%

15/06	Artivion Insider Sold Shares Worth $910,739, According to a Recent SEC Filing	MT
18/05	Artivion Closes $175 Million Acquisition of Endospan	MT

Evolution of the Average Target: Artivion, Inc.

Evolution of the Target Price: Artivion, Inc.

Changes in Analyst Recommendations: Artivion, Inc.

0f26568eaa85c9f.ToD-oKIGt_wcxDLLKlQCgO0pzwlHV1jgektfLg2mtKA.PN-w-tdq3ZhylgKqUDtQ56djtmE2BDWOP3MaHmDqx8kX5b-Z20j6j0WoXQ~defe7dbe60d9a61cffc45d4d9b5f869d

Analysts' recommendations: Artivion, Inc.

22/25/22	Needham Raises Price Target on Artivion to $50 From $45, Keeps Buy Rating	MT
08/25/08	Artivion Q2 revenue up 15%, beats analyst expectations	RE
08/24/08	Oppenheimer Raises Artivion Price Target to $32 From $30, Maintains Outperform Rating	MT
23/24/23	JMP Securities Initiates Artivion at Outperform With $33 Price Target	MT
09/24/09	Oppenheimer Adjusts Artivion Price Target to $30 From $25, Maintains Outperform Rating	MT
02/24/02	Lake Street Raises Price Target on Artivion to $30 From $28, Maintains Buy Rating	MT
07/24/07	Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating	MT
07/24/07	Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating	MT
16/24/16	Stifel Raises Price Target on Artivion to $22 From $20, Maintains Buy Rating	MT
08/23/08	Morgan Stanley Adjusts Price Target on Artivion to $15 From $14, Maintains Equal-Weight Rating	MT
05/23/05	Needham Adjusts Price Target on Artivion to $26 From $23, Maintains Buy Rating	MT
04/22/04	Needham Adjusts Price Target on Artivion to $23 From $28, Maintains Buy Rating	MT
11/22/11	Morgan Stanley Trims Artivion's Price Target to $14 From $16, Reiterates Equalweight Rating	MT
27/22/27	Oppenheimer Adjusts Artivion's Price Target to $25 From $35, Maintains Outperform Rating	MT
26/22/26	Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating	MT
26/22/26	Oppenheimer Adjusts Artivion Price Target to $25 From $35, Maintains Outperform Rating	MT
05/22/05	Needham Trims Artivion's Price Target to $28 From $29, Reiterates Buy Rating	MT
15/22/15	Morgan Stanley Adjusts Artivion's Price Target to $21 from $23, Keeps Equalweight Rating	MT
06/22/06	Needham Trims Artivion's Price Target to $29 From $30, Reiterates Buy Rating	MT
03/22/03	Stifel Starts Artivion at Buy With $30 Price Target	MT
18/22/18	Needham Adjusts Artivion's Price Target to $30 From $39 on 'Peer Multiple Compression;' Buy Rating Kept	MT
08/22/08	Morgan Stanley Lowers Price Target for CryoLife to $25 From $29, Maintains Equalweight Rating	MT
30/21/30	CRYOLIFE : Needham Adjusts CryoLife's Price Target to $39 From $38, Maintains Buy Rating	MT
15/21/15	CRYOLIFE : Morgan Stanley Starts CryoLife at Equal-Weight With $31 Price Target	MT
30/21/30	CRYOLIFE : Oppenheimer Adjusts CryoLife PT to $35 From $29, Maintains Outperform Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ARTIVION, INC.					+77.89%
	ABBOTT LABORATORIES					+23.82%
	MEDTRONIC PLC					+21.02%
	CENCORA, INC.					+22.67%
	HOYA CORPORATION					+18.79%
	BECTON, DICKINSON AND COMPANY					+14%
	MEDLINE INC.					+31.59%
	DEXCOM, INC.					+21.53%
	WEST PHARMACEUTICAL SERVICES, INC.					+2.26%
	STERIS PLC					+19.1%
	Average					+25.27%
	Weighted average by Cap.					+21.12%